[1] DeMichele AM, Moulder S, Buxton M, Yee D, Wallace A, Chien J, Isaacs C, et al. Efficacy of T-DM1+Pertuzumab over Standard Therapy for HER2+ Breast Cancer: Results from the Neoadjuvant I-SPY 2 TRIAL. Abstract: CT042 Presentation Session: Clinical Trials Plenary Session, Monday, April 18, 10:30 a.m. ? 12:30 p.m. CT, La Nouvelle Orleans Ballroom.
Home DeMichele AM, Moulder S, Buxton M
